During the past decade, ECOGENE-21 Clinical Trial Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ECOGENE-21 Clinical Trial Center" #1 collaborator was "The Clinical Trial Company" with 2 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "International Antiviral Therapy Evaluation Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ECOGENE-21 Clinical Trial Center" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Familial Lipoprotein Lipase Deficiency" (2 trials), "Diabetes" (1 trials) and "Hyperlipoproteinemia Type I" (1 trials). Many other conditions were trialed in "ECOGENE-21 Clinical Trial Center" in a lesser frequency.

Most popular intervention types in "ECOGENE-21 Clinical Trial Center" are "Drug" (4 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alipogene Tiparvovec (AMT-011), Human LPL [S447X]" (2 trials), "cyclosporine" (2 trials), "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials) and "Inclisiran" (1 trials). Other intervention names were less common.

The vast majority of trials in "ECOGENE-21 Clinical Trial Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "ECOGENE-21 Clinical Trial Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ECOGENE-21 Clinical Trial Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ECOGENE-21 Clinical Trial Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".